scispace - formally typeset
C

Christopher P. Hill

Researcher at University of Utah

Publications -  167
Citations -  16466

Christopher P. Hill is an academic researcher from University of Utah. The author has contributed to research in topics: Protein structure & Proteasome. The author has an hindex of 66, co-authored 165 publications receiving 15371 citations. Previous affiliations of Christopher P. Hill include Harvard University & Brookhaven National Laboratory.

Papers
More filters
Journal ArticleDOI

Ubiquitin-binding domains

TL;DR: This work has shown how binding specificity is determined, how ubiquitin binding is regulated, and the function of UBDs in the context of full-length proteins is controlled by studying their mechanism of action.
Journal ArticleDOI

Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid

TL;DR: The structure suggests how cyclophilin A can act as a sequence-specific binding protein and a nonspecific prolyl isomerase, and in the crystal lattice, capsid molecules assemble into continuous planar strips.
Journal ArticleDOI

Structure of the Carboxyl-Terminal Dimerization Domain of the HIV-1 Capsid Protein

TL;DR: Alignment of the CA(146-231) dimer with the crystal structure of the capsid amino-terminal domain provides a model for the intact protein and extends models for assembly of the central conical core of HIV-1.
Journal ArticleDOI

Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization.

TL;DR: The high-resolution crystal structure of defensin HNP-3 reveals a dimeric beta sheet that has an architecture very different from other lytic peptides, and suggests mechanisms by which defensins might bind to and permeabilize the lipid bilayer.
Journal ArticleDOI

X-Ray Structures of the Hexameric Building Block of the HIV Capsid

TL;DR: Methods for isolating soluble, assembly-competent CA hexamers are devised and derived four crystallographically independent models that define the structure of this capsid assembly unit at atomic resolution, which clarify the molecular basis for Capsid assembly inhibition and should facilitate structure-based drug design strategies.